U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
abrilumab [INN]
Preferred Name English
ABRILUMAB
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
AMG-181
Code English
IMMUNOGLOBULIN G, ANTI-(HUMAN INTEGRIN .ALPHA.4.BETA.7) (HUMAN MONOCLONAL HEAVY CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LIGHT CHAIN, DIMER
Common Name English
AMG 181
Code English
ABRILUMAB [USAN]
Common Name English
MEDI-7183
Code English
Abrilumab [WHO-DD]
Common Name English
MEDI7183
Code English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Mon Mar 31 22:54:46 GMT 2025 , Edited by admin on Mon Mar 31 22:54:46 GMT 2025
Code System Code Type Description
CAS
1342290-43-0
Created by admin on Mon Mar 31 22:54:46 GMT 2025 , Edited by admin on Mon Mar 31 22:54:46 GMT 2025
PRIMARY
USAN
AB-117
Created by admin on Mon Mar 31 22:54:46 GMT 2025 , Edited by admin on Mon Mar 31 22:54:46 GMT 2025
PRIMARY
INN
9921
Created by admin on Mon Mar 31 22:54:46 GMT 2025 , Edited by admin on Mon Mar 31 22:54:46 GMT 2025
PRIMARY
ChEMBL
CHEMBL2109628
Created by admin on Mon Mar 31 22:54:46 GMT 2025 , Edited by admin on Mon Mar 31 22:54:46 GMT 2025
PRIMARY
ChEMBL
CHEMBL2109294
Created by admin on Mon Mar 31 22:54:46 GMT 2025 , Edited by admin on Mon Mar 31 22:54:46 GMT 2025
PRIMARY
ChEMBL
CHEMBL3137351
Created by admin on Mon Mar 31 22:54:46 GMT 2025 , Edited by admin on Mon Mar 31 22:54:46 GMT 2025
PRIMARY
SMS_ID
300000021844
Created by admin on Mon Mar 31 22:54:46 GMT 2025 , Edited by admin on Mon Mar 31 22:54:46 GMT 2025
PRIMARY
FDA UNII
Y9UQ37XT2T
Created by admin on Mon Mar 31 22:54:46 GMT 2025 , Edited by admin on Mon Mar 31 22:54:46 GMT 2025
PRIMARY
WIKIPEDIA
Abrilumab
Created by admin on Mon Mar 31 22:54:46 GMT 2025 , Edited by admin on Mon Mar 31 22:54:46 GMT 2025
PRIMARY
NCI_THESAURUS
C139025
Created by admin on Mon Mar 31 22:54:46 GMT 2025 , Edited by admin on Mon Mar 31 22:54:46 GMT 2025
PRIMARY
DRUG BANK
DB15076
Created by admin on Mon Mar 31 22:54:46 GMT 2025 , Edited by admin on Mon Mar 31 22:54:46 GMT 2025
PRIMARY
ACTIVE MOIETY
ABRILUMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966